Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block Versus Bupivacaine Alone for Postoperative Pain Management in Patients Undergoing Craniotomy

NCT06993922 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT06993922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06993922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block Versus Bupivacaine Alone for Postoperative Pain Management in Patients Undergoing Craniotomy
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Recruiting
Start date
May 29, 2025
Completion date
November 1, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant, bupivacaine, craniotomy, dexmedetomidine, postoperative pain, scalp block